The effects of glucocorticoid therapy on the inflammatory and Dendritic cells in muscular dystrophies

被引:43
作者
Hussein, Mahmoud R.
Hamed, Sherifa A.
Mostafa, Mohammed G.
Abu-Dief, Eman E.
Kamel, Nageh Fouly
Kandil, Mahmoud R.
机构
[1] Assuit Univ Hosp, Dept Neurol & Histol, Assiut, Egypt
[2] Assiut Univ, Dept Pathol, Assiut, Egypt
[3] S Valley Univ, Fac Med, Dept Histol, Sohag, Egypt
关键词
Dendritic cells; glucocorticoid; muscular dystrophy;
D O I
10.1111/j.1365-2613.2006.00470.x
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Various clinical trials have documented the therapeutic benefit of glucocorticoids (GCs) in enhancing muscle strength and slowing disease progression of Duchenne and Becker muscular dystrophies (DMD/BMD). We hypothesized that GCs may have relevance to the differential anti-inflammatory effect on mononuclear inflammatory cells (MICs) and Dendritic cells (DCs) infiltrating the dystrophic muscles. In this prospective study, two muscle biopsies were obtained (before and after 6-month prednisone therapy) from 30 patients with dystrophies (DMD = 18; BMD = 6; and limb girdle muscular dystrophies (LGMD) = 6). MICs and DCs infiltrating the muscles were examined using mouse monoclonal antibodies and immunoperoxidase staining methods. Muscle strength was evaluated monthly by manual testing, motor ability and timed tests. Prednisone therapy was associated with: (i) functional improvement of overall motor disability, in upper limbs of DMD (P < 0.001) and BMD (P < 0.01) and lower limbs of DMD (P < 0.001) and BMD (P < 0.05); (ii) histological improvement such as fibre size variation (DMD, P < 0.01; BMD, P < 0.05), internalization of nuclei (DMD, P < 0.05), degeneration and necrosis (DMD and BMD, P < 0.01), regeneration (DMD, P < 0.001; BMD, P < 0.01) and endomysial connective tissue proliferation (DMD, P < 0.01; BMD, P < 0.05) and (iii) reduction of total MICs (P < 0.01) and DCs (P < 0.01). There was a positive correlation between the degree of improvement in overall motor disability and reduction of DCs numbers (In upper limbs; r = 0.638, P < 0.01 for DMD and r = 0.725, P < 0.01 for BMD, in Lower limbs; r = 0.547, P < 0.05 for DMD and r = 0.576, P < 0.05 for BMD). Such improvements and changes of MICs/DCs were absent in LGMD. In DMD/BMD, prednisone therapeutic effect was associated with reduced MICs and DCs numbers. Whether this therapeutic effect reflects targeting of the deleterious immune response produced by these cells mandates further investigations.
引用
收藏
页码:451 / 461
页数:11
相关论文
共 64 条
[1]   Regulation of cytokine and cytokine receptor expression by glucocorticoids [J].
Almawi, WY ;
Beyhum, HN ;
Rahme, AA ;
Rieder, MJ .
JOURNAL OF LEUKOCYTE BIOLOGY, 1996, 60 (05) :563-572
[2]  
AMANO Y, 1993, MOL PHARMACOL, V43, P176
[3]   ENORMOUS DYSTROPHIN IN A PATIENT WITH BECKER MUSCULAR-DYSTROPHY [J].
ANGELINI, C ;
BEGGS, AH ;
HOFFMAN, EP ;
FANIN, M ;
KUNKEL, LM .
NEUROLOGY, 1990, 40 (05) :808-812
[4]   MONOCLONAL-ANTIBODY ANALYSIS OF MONONUCLEAR-CELLS IN MYOPATHIES .1. QUANTITATION OF SUBSETS ACCORDING TO DIAGNOSIS AND SITES OF ACCUMULATION AND DEMONSTRATION AND COUNTS OF MUSCLE-FIBERS INVADED BY T-CELLS [J].
ARAHATA, K ;
ENGEL, AG .
ANNALS OF NEUROLOGY, 1984, 16 (02) :193-208
[5]  
ARCHIBALD K C, 1959, Arch Phys Med Rehabil, V40, P150
[6]   CONTROL OF CACHECTIN (TUMOR-NECROSIS-FACTOR) SYNTHESIS - MECHANISMS OF ENDOTOXIN RESISTANCE [J].
BEUTLER, B ;
KROCHIN, N ;
MILSARK, IW ;
LUEDKE, C ;
CERAMI, A .
SCIENCE, 1986, 232 (4753) :977-980
[7]   CLINICAL INVESTIGATION OF DUCHENNE MUSCULAR-DYSTROPHY - INTERESTING RESULTS IN A TRIAL OF PREDNISONE [J].
BROOKE, MH ;
FENICHEL, GM ;
GRIGGS, RC ;
MENDELL, JR ;
MOXLEY, RT ;
MILLER, JP ;
KAISER, KK ;
FLORENCE, JM ;
PANDYA, S ;
SIGNORE, L ;
KING, W ;
ROBISON, J ;
HEAD, RA ;
PROVINCE, MA ;
SEYFRIED, W ;
MANDEL, S .
ARCHIVES OF NEUROLOGY, 1987, 44 (08) :812-817
[8]   THE DIAGNOSTIC YIELD OF QUANTIFIED ELECTROMYOGRAPHY AND QUANTIFIED MUSCLE BIOPSY IN NEUROMUSCULAR DISORDERS [J].
BUCHTHAL, F ;
KAMIENIECKA, Z .
MUSCLE & NERVE, 1982, 5 (04) :265-280
[9]   DYSTROPHIN EXPRESSION AND SOMATIC REVERSION IN PREDNISONE-TREATED AND UNTREATED DUCHENNE DYSTROPHY [J].
BURROW, KL ;
COOVERT, DD ;
KLEIN, CJ ;
BULMAN, DE ;
KISSEL, JT ;
RAMMOHAN, KW ;
BURGHES, AHM ;
MENDELL, JR .
NEUROLOGY, 1991, 41 (05) :661-666
[10]   THE CLINICAL, GENETIC AND DYSTROPHIN CHARACTERISTICS OF BECKER MUSCULAR-DYSTROPHY .2. CORRELATION OF PHENOTYPE WITH GENETIC AND PROTEIN ABNORMALITIES [J].
BUSHBY, KMD ;
GARDNERMEDWIN, D ;
NICHOLSON, LVB ;
JOHNSON, MA ;
HAGGERTY, ID ;
CLEGHORN, NJ ;
HARRIS, JB ;
BHATTACHARYA, SS .
JOURNAL OF NEUROLOGY, 1993, 240 (02) :105-112